• Home
• People
  • Management
  • Scientific Advisors
  • Clinical Advisors
• Technology
• Product Pipeline
  • Vaccines
  • Tumor Immunotherapy
• News
• Presentations
• Publications
• Intellectual Property
• Investors
• Contact

Investors

Multimeric Biotherapeutics, Inc. is incorporated in Delaware as a C corporation. It seeks first round funding.

Interested investors are invited to contact:

Marc Hertz, Ph.D
Chief Executive Officer
mherz{at}multimericbio.com